Clinical trial

Melatonin Supplements for Improving Sleep in Individuals With Hypertension

NCT00238108 · Brigham and Women's Hospital, Other · Completed

Key facts

NCT number NCT00238108
Title Melatonin Supplements for Improving Sleep in Individuals With Hypertension
Official title Melatonin Supplementation in Hypertensive Patients
Lead sponsor Brigham and Women's Hospital, Other
Collaborators National Center for Complementary and Integrative Health (NCCIH) NIH Office of Dietary Supplements (ODS)
Status Completed
Phase Phase 2
Study type Interventional
Conditions Sleep Disorders, Hypertension
Intervention type Drug
Interventions Melatonin, Placebo
Enrollment 16
Start date Oct 1, 2005
Primary completion Aug 1, 2010
Completion Aug 1, 2010
First posted Oct 13, 2005
Last update posted Nov 14, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies